Literature DB >> 19247092

Successful treatment of esophageal cancer with airway invasion with induction chemotherapy and concurrent chemoradiotherapy.

Geoffrey Y Ku1, Karyn A Goodman, Valerie W Rusch, David H Ilson.   

Abstract

Esophageal cancer with airway invasion with or without fistula presents a challenging therapeutic dilemma with no standard therapy. Recent studies in Japan have focused on the use of definitive chemoradiotherapy. However, this approach is associated with significant treatment-related morbidity and mortality. We present a case report of a patient with thoracic esophageal squamous cell carcinoma with bronchial invasion who was treated to a clinical complete response with induction chemotherapy followed by consolidation with concurrent chemoradiotherapy. The patient also underwent restaging with a positron emission tomography scan after induction chemotherapy. Such a staged approach may reduce the morbidity of upfront radiation. The use of an interim positron emission tomography scan may also identify early treatment failure.

Entities:  

Mesh:

Year:  2009        PMID: 19247092     DOI: 10.1097/JTO.0b013e3181989efa

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


  3 in total

1.  Efficacy and Safety of Induction Chemotherapy in Esophageal Cancer with Airway Involvement.

Authors:  Vanita Noronha; Amit Joshi; Vijay M Patil; Nilendu Purandare; Sabita Jiwnani; Sarbani Ghosh-Laskar; Dipti Nakti; Bhavesh Bandekar; Kumar Prabhash
Journal:  J Gastrointest Cancer       Date:  2016-09

2.  Prognostic value of lymph node to primary tumor standardized uptake value ratio in unresectable esophageal cancer.

Authors:  Po-Jui Chen; Wing-Keen Yap; Yu-Chuan Chang; Chen-Kan Tseng; Yin-Kai Chao; Jason Chia-Hsun Hsieh; Ping-Ching Pai; Ching-Hsin Lee; Chan-Keng Yang; Albert Tsung-Ying Ho; Tsung-Min Hung
Journal:  BMC Cancer       Date:  2020-06-10       Impact factor: 4.430

3.  A Clinical Scoring Model to Predict the Effect of Induction Chemotherapy With Definitive Concurrent Chemoradiotherapy on Esophageal Squamous Cell Carcinoma Prognosis.

Authors:  Yang Li; Qingwu Du; Xiaoying Wei; Zhoubo Guo; Tongda Lei; Yanqi Li; Dong Han; Xiaoyue Wu; Kunning Zhang; Tian Zhang; Xi Chen; Jie Dong; Baozhong Zhang; Hui Wei; Wencheng Zhang; Qingsong Pang; Ping Wang
Journal:  Front Oncol       Date:  2021-11-29       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.